KRRONASDAQ Capital Market·USD·Closed·Healthcare · Biotechnology
Korro Bio, Inc.
$12.91−$0.35 · −2.64%day vs prior
Mkt Cap · USD
128.50M
P/E · TTM
-1.3
Div Yield · ann
–
52-week
$5.20 – $55.89
at 15% of range
Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.
Loading chart data...
Signal state